Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease
Year: 2009
Type: article
Source: Inflammatory Bowel Diseases
DOI: 10.1002/ibd.20999
Authors: C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller, D. Kelly
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: VSL#3, probiotics
Open Access status: closed
OpenAlex ID: W2087402298
